{"url":"https://lda.senate.gov/api/v1/filings/09d66dee-c1be-4dac-9da5-9e85865207c8/","filing_uuid":"09d66dee-c1be-4dac-9da5-9e85865207c8","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2018,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/09d66dee-c1be-4dac-9da5-9e85865207c8/print/","filing_document_content_type":"text/html","income":"50000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Meenakshi Datta","dt_posted":"2018-04-17T13:23:53.413000-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1501 K Street","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":35230,"url":"https://lda.senate.gov/api/v1/registrants/35230/","house_registrant_id":31204,"name":"SIDLEY AUSTIN LLP","description":"law firm","address_1":"1501 K Street","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"KYLE J. FIET","contact_telephone":"+1 202-736-8446","dt_updated":"2026-07-23T11:09:46.010671-04:00"},"client":{"id":143767,"url":"https://lda.senate.gov/api/v1/clients/143767/","client_id":1001867,"name":"PURDUE PHARMA L.P.","general_description":null,"client_government_entity":false,"client_self_select":null,"state":"CT","state_display":"Connecticut","country":"US","country_display":"United States of America","ppb_state":null,"ppb_state_display":null,"ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2012-03-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Patient access to abuse deterrent pain relief drugs","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":61778,"prefix":null,"prefix_display":null,"first_name":"DORA","nickname":null,"middle_name":null,"last_name":"HUGHES","suffix":null,"suffix_display":null},"covered_position":"Deputy Director of Health, HELP, Sen. Edward Kennedy; Health Policy Advisor, Sen. Barack Obama; Counselor for Science and Public Health, HHS","new":false},{"lobbyist":{"id":147219,"prefix":"ms","prefix_display":"MS.","first_name":"PATRICIA","nickname":null,"middle_name":"LOUISE","last_name":"DELOATCHE","suffix":null,"suffix_display":null},"covered_position":"Health Policy Director, Sen. Orrin Hatch; Chief of Staff, Legislative Director, and Legislative Assistant, Rep. Mike Bilirakis","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}